Repligen RGEN
NASDAQ RGEN
$164.68 -0.37 (-0.22%)
As of: Sep 10, 2026 · 3:59 PM EDT

Repligen (RGEN) Construction in Progress (2011 - 2025)

Repligen's (RGEN) quarterly Construction in Progress came in at $28.4 million in Q4 2025, up 0.67% year-over-year from $28.2 million in Q4 2024, and up 12.93% quarter-over-quarter from $25.1 million in Q3 2025.

Analysis

Repligen (RGEN) Construction in Progress (2011 - 2025) Analysis & Trends

Repligen (RGEN) has reported Construction in Progress for 15 consecutive years, with $28.4 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Construction in Progress rose 0.67% year-over-year to $28.4 million in Q4 2025; TTM through Dec 2025 was $28.4 million, a 0.67% increase from a year earlier, with the FY2025 full-year figure at $28.4 million, up 0.67% from the prior year.
  • Construction in Progress was $28.4 million for Q4 2025 at Repligen, up from $25.1 million in the prior quarter.
  • Over five years, Construction in Progress peaked at $77.8 million in Q2 2022 and troughed at $7.9 million in Q2 2021.
  • A 5-year average of $36.3 million and a median of $31.3 million in 2022 frame the typical range for Construction in Progress.
  • Across the five-year window, Construction in Progress soared 879.69% in 2022 and plunged 60.05% in 2023, its largest moves.
  • Over 5 years, Construction in Progress stood at $38.4 million in 2021, then dropped by 17.93% to $31.6 million in 2022, then surged by 49.23% to $47.1 million in 2023, then slumped by 40.09% to $28.2 million in 2024, then advanced by 0.67% to $28.4 million in 2025.
  • The last three Construction in Progress figures came in at $28.4 million (Q4 2025), $25.1 million (Q3 2025), and $25.9 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Thermo Fisher Scientific 223.99 Bn 219.93 Bn 8.34 Bn -
2 Danaher 141.56 Bn 137.22 Bn 3.61 Bn -
3 Agilent Technologies 40.36 Bn 38.60 Bn 1.04 Bn -
4 Illumina 30.41 Bn 29.24 Bn 770.00 Mn -
5 Revvity 13.50 Bn 12.48 Bn 416.87 Mn -
6 Bio-Techne 11.25 Bn 10.98 Bn 211.39 Mn -
7 Bio-Rad Laboratories 9.88 Bn 8.26 Bn 345.80 Mn -
8 Repligen 9.29 Bn 8.28 Bn 110.04 Mn -
9 10x Genomics 8.62 Bn 8.06 Bn 112.50 Mn -
10 Bruker 8.16 Bn 7.94 Bn 416.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 28.40 Mn
Sep 30, 2025 25.15 Mn
Jun 30, 2025 25.94 Mn
Mar 31, 2025 25.49 Mn
Dec 31, 2024 28.21 Mn
Sep 30, 2024 40.24 Mn
Jun 30, 2024 54.33 Mn
Mar 31, 2024 53.07 Mn
Dec 31, 2023 47.09 Mn
Sep 30, 2023 37.68 Mn
Jun 30, 2023 31.08 Mn
Mar 31, 2023 30.89 Mn
Dec 31, 2022 31.55 Mn
Sep 30, 2022 53.45 Mn
Jun 30, 2022 77.81 Mn
Mar 31, 2022 54.34 Mn
Dec 31, 2021 38.45 Mn
Sep 30, 2021 14.72 Mn
Jun 30, 2021 7.94 Mn
Mar 31, 2021 19.35 Mn